Drug Reduces Graft-Versus-Host After Stem Cell Transplant Doctors Lounge The chemokine receptor CCR5 antagonist maraviroc, which blocks lymphocyte trafficking, is safe and reduces the incidence of acute graft-versus-host disease in patients undergoing allogeneic hematopoietic stem-cell transplantation, according to a phase ... Drug Staves Off Graft-vs-Host Disease Maraviroc reduces incidence of GvHD in blood cancer patients after bone ... HIV Drug May Prevent Bone Marrow Transplant Complication |
